Research & Development

The rapid progression and accumulation of knowledge of cancer biology has accelerated identification of genes involved in diseases. Such information has been applied for the development of novel drugs, and led to the success of molecular-targeted drugs in cancer.

In the field of anti-cancer drugs, molecular-targeted therapies such as antibodies and small molecule compounds have been developed and their efficacy has been impressively proven in clinical practice. However, the number of molecular targeted drugs is still limited, and the development of novel drugs with high efficacy and a minimum risk of adverse events is expected in many kinds of cancers.

We at OncoTherapy Science, Inc. have been giving our best efforts to perform the research and development of novel molecular-targeted anti-cancer drugs using OTS’s fundamental technologies to deliver the light of hope to many patients suffering from cancers and relieve their anguish.

back to top